Assignee
EXONHIT THERAPEUTICS SA
FR·12 granted patents·9 pending applications·156 citations·filing 1998–2010
Top patents by PatentIndex Score
21 records- 0178US6552073B1Compounds and methods of treating cell proliferative diseasesEXONHIT THERAPEUTICS SA·Filed 2002·Granted Apr 22, 2003·19 cites·23 claims
- 0276US6372432B1Methods and composition for the detection of pathologic eventsEXONHIT THERAPEUTICS SA·Filed 1999·Granted Apr 16, 2002·46 cites·11 claims
- 0375US8003375B2Qualitative differential screeningEXONHIT THERAPEUTICS SA·Filed 2009·Granted Aug 23, 2011·0 cites·24 claims
- 0472US7790864B2Antibody to BACE455, an alternative splice variant of the human beta-secretaseEXONHIT THERAPEUTICS SA·Filed 2004·Granted Sep 7, 2010·7 cites·1 claims
- 0570US6251590B1Differential Qualitative screeningEXONHIT THERAPEUTICS SA·Filed 1998·Granted Jun 26, 2001·39 cites·25 claims
- 0669US2009264301A1Methods utilizing differential splicing events in blood cells for the detection of pathological eventsEXONHIT THERAPEUTICS SA·Filed 2009·Application pending·0 cites
- 0768US7514432B2Compounds and methods of treating cell proliferative diseases, retinopathies and arthritisEXONHIT THERAPEUTICS SA·Filed 2004·Granted Apr 7, 2009·6 cites·15 claims
- 0868US6881571B1Qualitative differential screeningEXONHIT THERAPEUTICS SA·Filed 1999·Granted Apr 19, 2005·27 cites·22 claims
- 0958US6855736B2Molecular target of neurotoxicityEXONHIT THERAPEUTICS SA·Filed 2001·Granted Feb 15, 2005·3 cites·7 claims
- 1058US2007027146A1Methods of treating nervous disordersEXONHIT THERAPEUTICS SA·Filed 2005·Application pending·0 cites
- 1157US2005043319A1Molecular target of neurotoxicityEXONHIT THERAPEUTICS SA·Filed 2004·Application pending·0 cites
- 1255US7923579B2Tricyclic hydroxamate and benzamide derivatives, compositions and methodsEXONHIT THERAPEUTICS SA·Filed 2004·Granted Apr 12, 2011·1 cites·7 claims
- 1355US2010204251A1Molecular target of neurotoxicityEXONHIT THERAPEUTICS SA·Filed 2009·Application pending·0 cites
- 1453US2009216014A1Novel compounds and methods of treating cell proliferative diseases, retinopathies and arthritisEXONHIT THERAPEUTICS SA·Filed 2009·Application pending·0 cites
- 1548US6509153B1Genetic markers of toxicity preparation and usesEXONHIT THERAPEUTICS SA·Filed 1999·Granted Jan 21, 2003·8 cites·25 claims
- 1648US2009269744A1Cancer detection methodEXONHIT THERAPEUTICS SA·Filed 2006·Application pending·0 cites
- 1745US2009317842A1Methods and Tools for The Therapy of Neurodegenerative PathologiesEXONHIT THERAPEUTICS SA·Filed 2007·Application pending·0 cites
- 1844US7872015B2Methods involving PDE4, compositions, and the screening thereof, for the treatment of degenerative ocular pathologiesEXONHIT THERAPEUTICS SA·Filed 2004·Granted Jan 18, 2011·0 cites·3 claims
- 1940US7834163B2Prostate specific genes and the use thereof as targets for prostate cancer therapyEXONHIT THERAPEUTICS SA·Filed 2004·Granted Nov 16, 2010·0 cites·5 claims
- 2040US2010317830A1Bace455, an alternative splice variant of the human beta-secretaseEXONHIT THERAPEUTICS SA·Filed 2010·Application pending·0 cites
- 2137US2008254031A1Tumor Specific Genes and Variant Rnas and Uses Thereof as Targets for Cancer Therapy and DiagnosisEXONHIT THERAPEUTICS SA·Filed 2005·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →